MRI-Compatible IV Infusion Pump - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The mRI-Compatible iV infusion pump market size in 2026 is estimated at USD 412.78 million, growing from 2025 value of USD 381.16 million with 2031 projections showing USD 614.98 million, growing at 8.30% CAGR over 2026-2031. This report is Segmented by Type (Non-Magnetic Pump Systems, and More), Magnetic-Field Compatibility (≤1. 5 T Systems, 3 T Systems, and More), Product Portability (Portable/Bedside Units, and More), End User (Hospitals, Specialty Clinics, and More) and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global MRI-Compatible IV Infusion Pump Market Trends and Insights

Rising Burden of Chronic Diseases & MRI Scan Volumes

Higher prevalence of cardiovascular, neurological, and oncological disorders raises the number of MRI studies that require uninterrupted drug infusion. The FDA’s updated MRI-device safety guidance gives manufacturers clearer routes to clearance, accelerating product launches. Tertiary hospitals are aggregating integrated MRI suites so that complex infusion regimens proceed without patient relocation. The aging demographic intensifies this demand, as multimorbidity often necessitates simultaneous imaging and therapy.

Growing MRI-Guided Minimally Invasive Surgeries

Real-time neuro, cardiac, and focused-ultrasound procedures need pumps that function inside 1.5 T, 3 T, and emerging 7 T magnets. GE HealthCare’s SIGNA MAGNUS 3.0 T head-only scanner exemplifies the ecosystem pulling infusion makers toward higher-field compatibility. Hospital capital budgets increasingly pair MRI upgrades with pump purchases because better image guidance shortens length of stay and lowers readmission risk.

High Capital & Maintenance Costs

Specialized engineering spikes unit prices, and smaller centers often delay upgrades. India’s public-sector MRI program illustrates cost-containment pressure by promising scanners at half prevailing import prices. Total ownership cost also includes maintenance contracts and magnet-room validation, prolonging payback periods.

Other drivers and restraints analyzed in the detailed report include:

• Advances in Wireless Non-Magnetic Pump Platforms
• IoT-Enabled Closed-Loop MRI Infusion Ecosystems
• Limited Reimbursement for MRI Disposables

Segment Analysis

Non-magnetic pumps accounted for 64.12% of the MRI-compatible IV infusion pump market share in 2025, as their ferrous-free architecture eliminates shielding constraints. This segment anchors the current MRI-compatible IV infusion pump market as large centers prioritize unrestricted patient positioning and workflow simplicity. The MRI-compatible IV infusion pump market size tied to non-magnetic units is forecasted to expand in parallel with the installation of new high-field scanners. Magnetic-shielded pumps are gaining traction, advancing at a 10.96% CAGR as compact shielding materials reduce cabinet bulk. B. Braun’s Space MRI Station features eight conventional pumps housed within a mu-metal cloak, appealing to hospitals that have already standardized on B. Braun software. Disposable tubing manufacturers are experimenting with BioDur 108 alloy to reduce the per-procedure cost while meeting sterility standards.

Achieving ultra-quiet operation inside the magnet bore is a core non-magnetic selling point. Clinicians report fewer alarms, reducing scan interruptions. Meanwhile, shielded models utilize familiar pump interfaces, thereby flattening the learning curve for staff who rotate between MRI and standard infusion rooms. Some tertiary centers mix both types: shielded racks for long oncology infusions and non-magnetic portables for anesthesia and contrast bolus work.

Scanners at ≤1.5 T currently account for 42.75% of the MRI-compatible IV infusion pump market share, mirroring installed base realities. However, ultra-high-field systems exhibit the fastest 11.35% CAGR because neuroscience and cardiac research institutes adopt 7 T magnets. The MRI-compatible IV infusion pump market size in this ultra-high-field niche is expected to grow as head-only and extremity scanners transition from research to clinical settings, leading to increased billing codes. Engineering challenges include eliminating eddy-current noise and ensuring Bluetooth telemetry survives intense gradients. Manufacturers collaborate with coil vendors to co-validate pump placement zones, shortening procurement cycles.

Mid-range 3 T machines remain radiology workhorses, sustaining steady replacement demand. Hospitals upgrading from 1.5 T to 3 T often bundle pump refreshes in the same capital cycle, a pattern vendors exploit by packaging service contracts. Payers in Europe are increasingly reimbursing 7T neuro scans for refractory epilepsy diagnostics, a policy catalyst that will nudge more centers toward ultra-high-field compatible pumps.

Complete Report Scope:

• By Type
  • Non-Magnetic Pump Systems
  • Magnetic-Shielded Pump Systems
  • Tubing & Disposables
• By Magnetic-Field Compatibility
  • ≤1.5 T Systems
  • 3 T Systems
  • Ultra-High-Field Systems
• By Product Portability
  • Portable/Bedside Units
  • Stationary Rack-mount Units
• By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Diagnostic & Imaging Centers
  • Research Institutes
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America retained 44.10% of the MRI-compatible IV infusion pump market size in 2025. The United States drives most placements thanks to early FDA clearances and a concentration of magnet-stocked academic medical centers. Canada’s provincial health systems fund capital grants for intra-operative MRI suites, sustaining replacement cycles. Mexico’s private hospital chains invest in turnkey surgical imaging theaters to attract medical tourists, creating incremental pump demand.Europe remains a mature adopter with stringent, predictable CE-mark pathways. Germany, France, and the United Kingdom favor network-ready pumps that comply with GDPR for device data. Scandinavian countries pilot closed-loop infusion protocols inside 3 T neurosurgical theaters, a model under review by EU health technology assessment bodies. Russia’s neuroscience institutes continue to import ultra-high-field capable pumps despite broader equipment sanctions, sustaining a small but resilient niche.

Asia-Pacific posts the strongest 12.98% CAGR. China’s National Health Commission earmarked funds for county-level MRI expansion, spurring local contract manufacturers to license Western pump IP and reduce import tariffs. India’s government-backed 1.5 T scanner line aspires to halve magnet pricing, indirectly lifting pump affordability. Japan pioneers IoT integration, linking infusion pumps with radiology scheduling systems to auto-populate drug libraries. Southeast Asian markets, led by Thailand and Indonesia, see private hospital groups differentiate premium packages with MRI-guided pain ablation services, fueling pump uptake.

The Middle East invests in flagship transplant centers where high-field MRI supports intra-op vascular mapping. Saudi Arabia’s Vision 2030 hospital projects include hybrid suites pre-wired for non-magnetic pumps. South America advances more slowly; however, Brazil’s top oncology institutes trial AI-assisted 3 T therapy workflows that require pump interoperability, hinting at future scale.

List of Companies Covered in this Report:

• IRadimed Corp.
• B. Braun
• Baxter
• Fresenius
• Becton Dickinson & Co.
• Medtronic
• ICU Medical
• Eitan Medical
• Arcomed AG
• Flowonix Medical Inc.
• Smiths Medical (ICU)
• Avanos Medical
• Moog Inc. (Curlin)
• Terumo Corp.
• Nipro Corp.
• Zyno Medical
• Shenzhen Mindray Bio-Medical
• CME-McKinley
• Bayer AG (MEDRAD)
• InfuSystem Holdings

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support